BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32497212)

  • 1. The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Van Vinh Chau N; Lam VT; Dung NT; Yen LM; Minh NNQ; Hung LM; Ngoc NM; Dung NT; Man DNH; Nguyet LA; Nhat LTH; Nhu LNT; Ny NTH; Hong NTT; Kestelyn E; Dung NTP; Xuan TC; Hien TT; Phong NT; Tu TNH; Geskus RB; Thanh TT; Truong NT; Binh NT; Thuong TC; Thwaites G; Van Tan L;
    Clin Infect Dis; 2020 Dec; 71(10):2679-2687. PubMed ID: 32497212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam.
    Thai PQ; Rabaa MA; Luong DH; Tan DQ; Quang TD; Quach HL; Hoang Thi NA; Dinh PC; Nghia ND; Tu TA; Quang N; Phuc TM; Chau V; Khanh NC; Anh DD; Duong TN; Thwaites G; van Doorn HR; Choisy M;
    Clin Infect Dis; 2021 May; 72(9):e334-e342. PubMed ID: 32738143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.
    Tutuncu EE; Ozgur D; Karamese M
    J Med Virol; 2021 May; 93(5):2932-2937. PubMed ID: 33501645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.
    Ra SH; Lim JS; Kim GU; Kim MJ; Jung J; Kim SH
    Thorax; 2021 Jan; 76(1):61-63. PubMed ID: 32963115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations.
    Ptasinska A; Whalley C; Bosworth A; Poxon C; Bryer C; Machin N; Grippon S; Wise EL; Armson B; Howson ELA; Goring A; Snell G; Forster J; Mattocks C; Frampton S; Anderson R; Cleary D; Parker J; Boukas K; Graham N; Cellura D; Garratt E; Skilton R; Sheldon H; Collins A; Ahmad N; Friar S; Burns D; Williams T; Godfrey KM; Deans Z; Douglas A; Hill S; Kidd M; Porter D; Kidd SP; Cortes NJ; Fowler V; Williams T; Richter A; Beggs AD
    Clin Microbiol Infect; 2021 Sep; 27(9):1348.e1-1348.e7. PubMed ID: 33901668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.
    Edlow AG; Li JZ; Collier AY; Atyeo C; James KE; Boatin AA; Gray KJ; Bordt EA; Shook LL; Yonker LM; Fasano A; Diouf K; Croul N; Devane S; Yockey LJ; Lima R; Shui J; Matute JD; Lerou PH; Akinwunmi BO; Schmidt A; Feldman J; Hauser BM; Caradonna TM; De la Flor D; D'Avino P; Regan J; Corry H; Coxen K; Fajnzylber J; Pepin D; Seaman MS; Barouch DH; Walker BD; Yu XG; Kaimal AJ; Roberts DJ; Alter G
    JAMA Netw Open; 2020 Dec; 3(12):e2030455. PubMed ID: 33351086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals.
    Tallmadge RL; Laverack M; Cronk B; Venugopalan R; Martins M; Zhang X; Elvinger F; Plocharczyk E; Diel DG
    Microbiol Spectr; 2022 Jun; 10(3):e0226421. PubMed ID: 35575498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time.
    Yousaf AR; Duca LM; Chu V; Reses HE; Fajans M; Rabold EM; Laws RL; Gharpure R; Matanock A; Wadhwa A; Pomeroy M; Njuguna H; Fox G; Binder AM; Christiansen A; Freeman B; Gregory C; Tran CH; Owusu D; Ye D; Dietrich E; Pevzner E; Conners EE; Pray I; Rispens J; Vuong J; Christensen K; Banks M; O'Hegarty M; Mills L; Lester S; Thornburg NJ; Lewis N; Dawson P; Marcenac P; Salvatore P; Chancey RJ; Fields V; Buono S; Yin S; Gerber S; Kiphibane T; Dasu T; Bhattacharyya S; Westergaard R; Dunn A; Hall AJ; Fry AM; Tate JE; Kirking HL; Nabity S
    Clin Infect Dis; 2021 Oct; 73(7):e1841-e1849. PubMed ID: 32719874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam.
    Chau NVV; Hong NTT; Ngoc NM; Thanh TT; Khanh PNQ; Nguyet LA; Nhu LNT; Ny NTH; Man DNH; Hang VTT; Phong NT; Que NTH; Tuyen PT; Tu TNH; Hien TT; Minh NNQ; Hung LM; Truong NT; Yen LM; Rogier van Doorn H; Dung NT; Thwaites G; Dung NT; Van Tan L;
    Emerg Infect Dis; 2021 Jan; 27(1):310-4. PubMed ID: 33063657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period.
    Srichatrapimuk S; Chookajorn T; Kochakarn T; Kirdlarp S; Pasomsub E; Chantratita W; Iamsirithaworn S; Kunakorn M; Thitithanyanont A; Sungkanuparph S; Phuphuakrat A
    Travel Med Infect Dis; 2022; 46():102271. PubMed ID: 35123068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.
    Park SK; Lee CW; Park DI; Woo HY; Cheong HS; Shin HC; Ahn K; Kwon MJ; Joo EJ
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1387-1394.e2. PubMed ID: 32534042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of Molecular and Antigen Test Performance for SARS-CoV-2 in Symptomatic and Asymptomatic COVID-19 Contacts.
    Robinson ML; Mirza A; Gallagher N; Boudreau A; Garcia Jacinto L; Yu T; Norton J; Luo CH; Conte A; Zhou R; Kafka K; Hardick J; McManus DD; Gibson LL; Pekosz A; Mostafa HH; Manabe YC
    J Clin Microbiol; 2022 Jul; 60(7):e0018722. PubMed ID: 35730949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) viral positivity and their burden in saliva of asymptomatic carriers - a systematic review and meta-analysis.
    Fakhruddin KS; Haiat A; Ngo HC; Panduwawala C; Chang JWW; Samaranayake LP
    Acta Odontol Scand; 2022 Apr; 80(3):182-190. PubMed ID: 34689688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Performance of Direct RT-PCR Testing of Raw Saliva for Detection of SARS-CoV-2 in Symptomatic and Asymptomatic Individuals.
    Castillo-Bravo R; Lucca N; Lai L; Marlborough K; Brychkova G; Sakhteh MS; Lonergan C; O'Grady J; Alikhan NF; Trotter AJ; Page AJ; Smyth B; McKeown PC; Feenstra JDM; Ulekleiv C; Sorel O; Gandhi M; Spillane C
    Microbiol Spectr; 2022 Dec; 10(6):e0222922. PubMed ID: 36409097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.